Biomedical/Medical Engineering at Binghamton University

Binghamton's biomedical engineering program presents a financial paradox: graduates start behind the curve at $59,000—about $5,600 below the national median—but surge ahead to $75,680 by year four, surpassing both national and state benchmarks. This 28% earnings growth suggests the program's value reveals itself over time, though you're essentially betting on delayed returns rather than immediate market positioning. Among New York's 15 biomedical engineering programs, Binghamton sits squarely in the middle of the pack, trailing engineering powerhouses like RPI and RIT by a significant margin.

The debt picture is genuinely compelling: at $19,000, it's nearly $4,000 below the state median and $4,200 below the national benchmark. This translates to a debt-to-earnings ratio of just 0.32—manageable even with the slower initial earnings. For context, you're looking at monthly payments around $200 on a standard plan, which is digestible even on that first-year salary.

The bottom line: This is a solid choice for families prioritizing affordability over prestige, particularly if your child is willing to play the long game. The trajectory is right—earnings that climb steadily rather than plateau—and the debt burden won't constrain early career choices. Just understand you're choosing value over the brand recognition and industry connections that come with higher-ranked engineering schools in the state.